全文获取类型
收费全文 | 6835篇 |
免费 | 443篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 170篇 |
妇产科学 | 118篇 |
基础医学 | 980篇 |
口腔科学 | 104篇 |
临床医学 | 679篇 |
内科学 | 1768篇 |
皮肤病学 | 155篇 |
神经病学 | 653篇 |
特种医学 | 169篇 |
外国民族医学 | 1篇 |
外科学 | 672篇 |
综合类 | 48篇 |
一般理论 | 5篇 |
预防医学 | 661篇 |
眼科学 | 137篇 |
药学 | 391篇 |
中国医学 | 43篇 |
肿瘤学 | 510篇 |
出版年
2023年 | 89篇 |
2022年 | 193篇 |
2021年 | 317篇 |
2020年 | 140篇 |
2019年 | 205篇 |
2018年 | 236篇 |
2017年 | 161篇 |
2016年 | 179篇 |
2015年 | 213篇 |
2014年 | 263篇 |
2013年 | 367篇 |
2012年 | 494篇 |
2011年 | 539篇 |
2010年 | 217篇 |
2009年 | 208篇 |
2008年 | 370篇 |
2007年 | 334篇 |
2006年 | 348篇 |
2005年 | 296篇 |
2004年 | 308篇 |
2003年 | 281篇 |
2002年 | 273篇 |
2001年 | 89篇 |
2000年 | 84篇 |
1999年 | 80篇 |
1998年 | 52篇 |
1997年 | 45篇 |
1996年 | 39篇 |
1995年 | 33篇 |
1994年 | 26篇 |
1993年 | 29篇 |
1992年 | 46篇 |
1991年 | 44篇 |
1990年 | 33篇 |
1989年 | 42篇 |
1988年 | 23篇 |
1987年 | 36篇 |
1986年 | 18篇 |
1985年 | 28篇 |
1984年 | 16篇 |
1983年 | 19篇 |
1982年 | 25篇 |
1981年 | 14篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1977年 | 13篇 |
1975年 | 13篇 |
1973年 | 21篇 |
1968年 | 13篇 |
1919年 | 16篇 |
排序方式: 共有7302条查询结果,搜索用时 12 毫秒
41.
Francisco A. O. Júnior Clara R. Ruiz Yohanna de Oliveira Marco A. V. Barros Alexandre S. Silva Maria S. B. Santos Vinícius J. B. Martins Camille M. Balarini Valdir A. Braga 《Nutrients》2021,13(3)
Exploring an alternative to improve the clinical management of hypertension, we tested the hypothesis that food supplementation with coconut oil (EVCO), alone or combined with aerobic exercise training, could exert an antihypertensive effect (primary outcome) in patients with stage 1 hypertension. Forty-five hypertensive volunteers of both genders participated in a placebo-controlled clinical trial. The volunteers were submitted to 24-hour ambulatory blood pressure monitoring, analysis of blood pressure variability (BPV), measurement of serum malondialdehyde (MDA) and nutritional assessment. Results indicate that EVCO consumption had no adverse effects. The supplementation did not increase the caloric intake compared with placebo, and the dietary constituents were similar between groups, except for the saturated fats, especially lauric acid. The analysis of blood pressure indicated absence of antihypertensive effect of EVCO alone or combined with physical training. Furthermore, no effects on blood pressure variability and oxidative stress were observed in the supplemented hypertensive patients. Thus, despite the results observed in pre-clinical studies, the current clinical study did not provide evidence to support the use of coconut oil as an adjuvant in the management of hypertension in humans. 相似文献
42.
Erin Tutty Chriselle Hickerton Bronwyn Terrill Belinda McClaren Rigan Tytherleigh Elaine Stackpoole Jaqueline Savard Ainsley Newson Anna Middleton Amy Nisselle Marie Cusack Melissa Adamski Clara Gaff Sylvia Metcalfe 《Health expectations》2021,24(2):670
BackgroundConsumer genomic testing for nutrition and wellness, (nutritional genomics), is becoming increasingly popular. Concurrently, health‐care practitioners (HPs) working in private practice (including doctors interested in integrative medicine, private genetic counsellors, pharmacists, dieticians, naturopaths and nutritionists) are involved as test facilitators or interpreters.ObjectiveTo explore Australian consumers’ and HPs’ experiences with nutrigenomic testing.MethodSemi‐structured in‐depth interviews were conducted using predominantly purposive sampling. The two data sets were analysed individually, then combined, using a constant comparative, thematic approach.ResultsOverall, 45 interviews were conducted with consumers (n = 18) and HPs (n = 27). Many of the consumer interviewees experienced chronic ill‐health. Nutrigenomic testing was perceived as empowering and a source of hope for answers. While most made changes to their diet/supplements post‐test, self‐reported health improvements were small. A positive relationship with their HP appeared to minimize disappointment. HPs’ adoption and views of nutrigenomic testing varied. Those enthusiastic about testing saw the possibilities it could offer. However, many felt nutrigenomic testing was not the only ‘tool’ to utilize when offering health care.DiscussionThis research highlights the important role HPs play in consumers’ experiences of nutrigenomics. The varied practice suggests relevant HPs require upskilling in this area to at least support their patients/clients, even if nutrigenomic testing is not part of their practice.Patient or public contributionAdvisory group included patient/public group representatives who informed study design; focus group participants gave feedback on the survey from which consumer interviewees were sourced. This informed the HP data set design. Interviewees from HP data set assisted with snowball sampling. 相似文献
43.
44.
Annals of Surgical Oncology - 相似文献
45.
46.
47.
Mozafarinia Maryam Rajabiyazdi Fateme Brouillette Marie-Josee Fellows Lesley K. Mayo Nancy E. 《Quality of life research》2021,30(11):3199-3211
Quality of Life Research - (1) To develop a personalized health outcome profile as a feedback tool to improve self-management in people living with chronic conditions such as HIV and (2) to... 相似文献
48.
Peasgood Tessa Chang Jen-Yu Mir Robina Mukuria Clara Powell Philip A. 《Quality of life research》2021,30(7):2097-2108
Quality of Life Research - Uncertainties exist in how respondents interpret response options in patient-reported outcome measures (PROMs), particularly across different domains and for different... 相似文献
49.
Julien Favresse Constant Gillot Jean-Louis Bayart Clara David Germain Simon Loris Wauthier Mélanie Closset Jean-Michel Dogné Jonathan Douxfils 《Journal of medical virology》2023,95(1):e28164
Evidence about the long-term persistence of the booster-mediated immunity against Omicron is mandatory for pandemic management and deployment of vaccination strategies. A total of 155 healthcare professionals (104 COVID-19 naive and 51 with a history of SARS-CoV-2 infection) received a homologous BNT162b2 booster. Binding antibodies against the spike protein and neutralizing antibodies against Omicron were measured at several time points before and up to 6 months after the booster. Geometric mean titers of measured antibodies were correlated to vaccine efficacy (VE) against symptomatic disease. Compared to the highest response, a significant 10.2- and 11.5-fold decrease in neutralizing titers was observed after 6 months in participants with and without history of SARS-CoV-2 infection. A corresponding 2.5- and 2.9-fold decrease in binding antibodies was observed. The estimated T1/2 of neutralizing antibodies in participants with and without history of SARS-CoV-2 infection was 42 (95% confidence interval [CI]: 25–137) and 36 days (95% CI: 25–65). Estimated T1/2 were longer for binding antibodies: 168 (95% CI: 116–303) and 139 days (95% CI: 113–180), respectively. Both binding and neutralizing antibodies were strongly correlated to VE (r = 0.83 and 0.89). However, binding and neutralizing antibodies were modestly correlated, and a high proportion of subjects (36.7%) with high binding antibody titers (i.e., >8434 BAU/ml) did not have neutralizing activity. A considerable decay of the humoral response was observed 6 months after the booster, and was strongly correlated with VE. Our study also shows that commercial assays available in clinical laboratories might require adaptation to better predict neutralization in the Omicron era. 相似文献
50.
Safavy A Khazaeli MB Mayo MS Buchsbaum DJ 《Cancer biotherapy & radiopharmaceuticals》1997,12(6):375-384
Our previous results indicated that the trihydroxamate ligand, trisuccin, was a promising bifunctional chelating agent (BCA) for radiometal labeling of monoclonal antibodies with rhenium and technetium. An interest was developed to evaluate structural modifications of this compound from both synthetic and biological points of view. In this report we describe the synthesis of an esterified trisuccin (referred to as trisester), and conjugation of this new derivative to MAb CC49, radiolabeling of this conjugate with rhenium-188 (188Re), and biodistribution of the labeled conjugate in athymic nude mice. Thus, trisuccin (1) was esterified with benzyl 4-hydroxybenzoate in a DCC/DMAP reaction followed by removal of all benzyl protecting groups with catalytic hydrogenation. The resulting product was conjugated to CC49 by the active ester technique, through formation of the 2-nitrophenyl ester 6, and the conjugate was radiolabeled with generator-produced 188Re. The lead molecule trisuccin 1 was also conjugated to CC49 through the active ester 5 and the conjugate was radiolabeled by the same procedure to serve as the control conjugate. Biodistributions of the labeled conjugates were studied in athymic nude mice, transplanted s.c. with LS174T human colon cancer xenografts. Although an increase in the radiolabeling yield was observed for the esterified ligand-CC49 conjugate, as well as some increase in its immunoreactivity, as compared to those for the parent trisuccin molecule, there were no significant differences in their biodistribution. This new compound therefore may be useful in improving the conjugation and radiolabeling chemistries of this trihydroxamate ligand system. 相似文献